Clinical and Imaging Progression in the PARS Cohort: Long‐Term Follow‐up

Abstract

The PARS (Parkinson Associated Risk Syndrome) study was designed to test whether screening for hyposmia followed by dopamine transporter imaging can identify risk for conversion to clinical PD, and to evaluate progression markers during the prodromal period.

Document Details

• Document Type: Pub Defense Publication
• Publication Date: Jul 13, 2020
• Source ID: 10.1002/mds.28139

Entities

People

• Andrew Siderowf
• Danna Jennings
• David Oakes
• For The Pars Investigators
• John Seibyl
• Kenneth Marek
• Matthew Stern
• Shirley Eberly

Organizations

• Institute for Neurodegenerative Disorders
• United States Department of Defense
• University of Pennsylvania
• University of Rochester

Tags

Fields of Study

• Medicine

Readers

• Mental Health of Military Veterans with Posttraumatic Stress Disorder (PTSD): Risk Factors, Prevalence, Symptoms, and Treatment.
• Neurodegenerative Parkinson's Disease and Rickettsial Disease handbook, including the data level of dopamine, BC, neurons, and PD.